Error-prone DNA replication and repair may lead to mutations and cancer in individuals who inherit a mutant copy of the BRCA1 gene, according to a new study by Weill Cornell Medicine investigators. The discovery has potential ...
Nov 15, 2022
0
27
Two factors contribute to the lung disease bronchopulmonary dysplasia, or BPD, in extremely premature infants: the high oxygen concentrations that premature infants need to aid their breathing and a microbial dysbiosis in ...
Nov 14, 2022
0
6
While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot get vaccinated or in the event that dangerous new strains ...
Nov 14, 2022
0
120
Researchers at the University of Pennsylvania's Basser Center for BRCA at the Abramson Cancer Center have discovered factors that may make breast and ovarian cancers associated with BRCA1/2 gene mutations more likely to recur.
Nov 10, 2022
0
134
Using cutting edge molecular techniques in rodent models, researchers are dissecting the neurobiological mechanisms impacted by early life adversity. The findings were presented at Neuroscience 2022, the annual meeting of ...
Nov 9, 2022
0
4
Multiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibodies. It is the second most common hematologic cancer, accounting for 2% of all cancers of hematologic origin.
Nov 9, 2022
0
14
In the battle of the sexes, women beat men in their ability to recover from kidney injury, but the reasons are not well understood.
Nov 8, 2022
0
54
Since the start of her career, Jennifer DeLuca has been fascinated by mitosis, the everyday biological process of cell division: how it works, which proteins and cellular machineries are involved, and why it sometimes goes ...
Nov 7, 2022
0
49
Researchers at VCU Massey Cancer Center have published new study findings that establish rationale for the use of a class of drugs known as MDA-9 inhibitors as a potential treatment option for aggressive liver cancer. The ...
Nov 3, 2022
0
16
A new model for understanding which patients with sepsis, COVID-19 and influenza have immune dysfunction and are more likely to suffer poor outcomes has been developed by researchers at the Wellcome Sanger Institute, the ...
Nov 2, 2022
0
35
